Practique Clinique et Investigation

Home

Practique Clinique et Investigation (Clinical Practice & Investigation) from June, 2019 is an International multidisciplinary, peer reviewed scholarly journal that provides an open access platform for the worldwide distribution of original and novel scientific manuscripts/articles based on the various aspects of the adept practical approaches to disease management. The priority of the journal is to publish manuscripts that provide useful insights into the real time efficacy and persisting lacunae in the various principles, tools and techniques involved in the diagnosis and treatment of acute and chronic diseases. The journal serve as a bond between the clinical and medical community and the general society by dispersing scientific advancements in medical and clinical research.

Publishing fees
At this stage, the submission and publication of manuscripts is at huge discount for all students/emeritus professor. The published articles are made freely available to online readers.

Authors Funded by the NIH: This journal automatically deposits papers to PubMed Central after publication of an issue (NIHMS, http://nihms.nih.gov/).


COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC    https://www.coronavirus.gov
Get the latest research    https://www.who.int/emergencies/diseases/novel-coronavirus-2019


 

Acceptance Rate
75%
Days to process
45
Days to publish
10
Total Articles
26

Recently Published Articles

Research Article | Volume 3, Issue 2 | Open Access
Evaluation of Implant Time of VVI and DDD Pacemakers in Sub-Saharan Africa Center

Emmmanuel A Edafe

Editor Note | Volume 3, Issue 1 | Open Access
Corona Virus all Over the World! PANDEMIC

Khalid Aftab

Short Communication | Volume 3, Issue 1 | Open Access
Recent Studies Suggest Kids are as Likely to be Infected as Adults & Experimental Corona Virus Vaccine

Khalid Aftab

Research Article | Volume 3, Issue 1 | Open Access
Interplay of Malaria and Intestinal Helminths Co-infection among Pregnant Women in Port Harcourt, Niger Delta Region of Nigeria

Azuonwu Obioma | Ihua Nnnena | Porokie Nekabari C

Research Article | Volume 3, Issue 1 | Open Access
Spermatogonia Apoptosis Induction as a Possible Mechanism of Toxoplasma Gondii Induced Male Infertility

Sorush Niknamian

Research Article | Volume 3, Issue 1 | Open Access
Laboratory Investigations for safe and efficacious use of Opened Multi-Dose Vials of Bivalent Oral Polio Vaccine

Amit Kumar | Sudhir Kumar Singh | Ritaj Kumar Rai | Abhishek Kumar

Research Article | Volume 3, Issue 1 | Open Access
How can we develop immunity against COVID-19 and defeat it

Pramod Stephen

Review Article | Volume 2, Issue 2 | Open Access
Diagnosis and Management of Nosocomial Sinusitis in Critical Care Units: Review of Literature

Nahla Shaaban Khalil

Research Article | Volume 2, Issue 2 | Open Access
Physical and Rehabilitation Physicians’ Perception and Attitude Towards Mobile Health Application in Saudi Arabia

Bander Alkhudairi | Mohammed Alkarni

Research Article | Volume 2, Issue 2 | Open Access
Correlations among the RTS, ISS and TRISS trauma indices in different types of chest injury

Jose Maria Pereira de Godoy | Francisco de Assis Cury | André Luís Baitelo| Maria de Fatima Guerreiro Godoy

Aims & Scope

Practique Clinique et Investigation (Clinical Practice & Investigation) is dedicated to systematic coverage of the methodology, progress and outcomes of clinical trials, clinical practice and clinical research. As a peer-reviewed, tri-annually publication. It provides a forum for the rapid publication of original research and critically reviews the latest developments in medical research, from Phase 1 trials through to post-marketing studies and pharmaco-economic research.

Each and every year new therapeutic entities enter for clinical use, only one of every 10,000 potential medicines survive the development and approval process. The process of clinical research is highly expensive, involved and complex, with huge demands placed on investigators to deliver robust, reproducible data and to meet the exacting requirements of regulatory authorities.

The scope of the journal:

  • Implementation of complementary therapies (CTs) in the clinical setting
  • Legal and ethical concerns
  • Evaluative accounts of therapy in practice
  • Philosophical analysis of emergent social trends in CTs
  • Excellence in clinical judgement
  • Problem management
  • Therapy information
  • Policy development and management of change in order to promote safe and efficacious clinical practice.
  • Clinical study design and methodology
  • Overviews of the clinical progress of new drugs or drug classes
  • Clinical progress for specific diseases or therapeutic areas
  • Findings in Phase I to IV clinical studies
  • Healthcare outcomes and pharmacoeconomics
  • Patient stratification and individualized therapies
  • Commentary on trials in progress
  • Drug safety issues and adverse event monitoring
  • Biomarkers in clinical trials
  • Regulatory issues
  • Clinical trial data management and statistics